Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 July 2022 | Story Lunga Luthuli

From an early age, many have been taught that strangers are not only a danger to the individual, but to the communities too.

A StrangerKind (ASK), an organisation hosting unconventional conversations in communities on topics and responding to questions that many may not have the opportunity to ask, has partnered with the University of the Free State to host the talks that aims to promote curiosity, diversity, and social cohesion.

As part of the ASKcampus – a first to be hosted at any university in the country – participants will have an opportunity to talk to a stranger in a safe setting and ask any question that comes to mind, without any judgement.

Michelle Nöthling, Assistant Researcher in Kovsie Support Services, said: “The ASK event is an opportunity for participants to pick a topic from a list that sparks curiosity and book an available 45-minute time slot. During your session, you sit down to a one-on-one conversation with a stranger who will briefly introduce themselves and their topic. They will then share their personal life experience on that topic with you.”

The event, which will be launched at the Thakaneng Bridge, Bloemfontein Campus, on 28 July 2022, is open to both UFS staff and students.

“During the individual sessions, participants may ask the strangers anything about the chosen topic. We even encourage you to ask those questions that you might otherwise have been too shy, or felt were too ignorant, to ask. What is more, is that the strangers you will meet will be fellow UFS staff and students. But you will not know who your stranger is until you sit down with them,” said Michelle.

Individuals who want to know more about becoming a UFS stranger are encouraged to visit the organisation’s YouTube channel or register to attend training and become a ‘stranger’.

Be curious. Be brave. Talk to strangers.

Launch details:
Date
: 28 July 2022
Time
: 10:00-14:00
Venue
: Thakaneng Bridge, Bloemfontein Campus

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept